A critical discovery in cancer study is arising with the use of nanobodies to re-engage dysfunctional p53. This crucial cancer suppressor protein is frequently inactivated in many types of malignancies, resulting https://minibookmarking.com/story22085816/nanobodies-reactivate-tumor-suppressor-p53-new-new-pathway-for-malignant-therapy